<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Paris_Saclay_Notebook_October_6 skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Paris Saclay/Notebook/October/6</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="container-fluid nav-container"><NAV class="navbar navbar-default navbar-inverse affix-top" data-spy="affix" data-offset-top="260"><DIV class="container-fluid"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" aria-expanded="false"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV><DIV class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"><UL class="nav navbar-nav center-block"><LI><A href="https://2016.igem.org/Team:Paris_Saclay">Home</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Team</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Team">Team</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Media">Media</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Collaborations">Collaborations</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Sponsors">Sponsors</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Acknowledgements">Acknowledgements</A></LI></UL><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Project </A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Background">Background</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Design">Design</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/CRISPR-Cas9">CRISPR/Cas9</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Strategy">Strategy</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Experiments">Experiments</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Notebook">Notebook</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Description">Results</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Perspective">Perspective</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Interlab_Study">Interlab Study</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Parts">Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Basic_Part">Basic Parts</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Composite_Part">Composite Parts</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Human Pratices </A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Human_Practices">Overview</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/HP/Silver">Societal Issues of CRISPR/Cas9</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/HP/Gold">Responsible Research and Innovation</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Human_Practices/GMO_Regulation">GMO regulation</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Integrated_Practices">Integrated Practices</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Engagement">Engagement</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Model">Model</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Attributions">Attributions</A></LI><LI><A href="https://2016.igem.org/Team:Paris_Saclay/Safety">Safety</A></LI></DIV></DIV></NAV></DIV><DIV class="container content"><DIV id="main"><DIV id="toc" class="toc"><DIV id="toctitle"><H2>Contents</H2></DIV><UL><LI class="toclevel-1 tocsection-1"><A href="#Thursday_6th_October"><SPAN class="tocnumber">1</SPAN><SPAN class="toctext">Thursday 6<SUP>th</SUP> October</SPAN></A></LI><LI class="toclevel-2 tocsection-2"><A href="#Visualization"><SPAN class="tocnumber">1.1</SPAN><SPAN class="toctext">Visualization</SPAN></A></LI><LI class="toclevel-3 tocsection-3"><A href="#Plasmids_extraction_of_FRB_-_GFP_11_in_pSB1C3_.28pPS16_019.29_clone_4_and_FKBP_-_GFP_10_in_pSB1C3_.28pPS16_018.29_clone_6"><SPAN class="tocnumber">1.1.1</SPAN><SPAN class="toctext">Plasmids extraction of FRB - GFP 11 in pSB1C3 (pPS16_019) clone 4 and FKBP - GFP 10 in pSB1C3 (pPS16_018) clone 6</SPAN></A></LI><LI class="toclevel-3 tocsection-4"><A href="#Transformation_of_DH5a_cells_with_and_FKBP_-_GFP_10_.28pPS16_018.29_and_FRB_-_GFP_11_.28pPS16_019.29"><SPAN class="tocnumber">1.1.2</SPAN><SPAN class="toctext">Transformation of DH5a cells with and FKBP - GFP 10 (pPS16_018) and FRB - GFP 11 (pPS16_019)</SPAN></A></LI></UL><LI class="toclevel-2 tocsection-5"><A href="#BioBrick_K2039000_and_K2039001_characterization"><SPAN class="tocnumber">1.2</SPAN><SPAN class="toctext">BioBrick K2039000 and K2039001 characterization</SPAN></A></LI><LI class="toclevel-3 tocsection-6"><A href="#Culture_of_FRB_-_GFP_11_in_pSB1C3_.28pPS16_019.29_clone_4.2C_FKBP_-_GFP_10_in_pSB1C3_.28pPS16_018.29_clone_6.2C_GFP_1.9_in_pUC19_.28pPS16_009.29_clone_1_and_PhB1040_strain_594"><SPAN class="tocnumber">1.2.1</SPAN><SPAN class="toctext">Culture of FRB - GFP 11 in pSB1C3 (pPS16_019) clone 4, FKBP - GFP 10 in pSB1C3 (pPS16_018) clone 6, GFP 1.9 in pUC19 (pPS16_009) clone 1 and PhB1040 strain 594</SPAN></A></LI></DIV><H1><SPAN class="mw-headline" id="Thursday_6th_October">Thursday 6<SUP>th</SUP> October</SPAN></H1><H3><SPAN class="mw-headline" id="Visualization">Visualization</SPAN></H3><H4><SPAN class="mw-headline" id="Plasmids_extraction_of_FRB_-_GFP_11_in_pSB1C3_.28pPS16_019.29_clone_4_and_FKBP_-_GFP_10_in_pSB1C3_.28pPS16_018.29_clone_6">Plasmids extraction of FRB - GFP 11 in pSB1C3 (pPS16_019) clone 4 and FKBP - GFP 10 in pSB1C3 (pPS16_018) clone 6</SPAN></H4><P><I>By Maxence &amp; Victor</I></P><P>The following plasmids were extracted using the <A href="/Team:Paris_Saclay/Experiments#InvitrogenPlasmidExtraction" title="Team:Paris Saclay/Experiments">&quot;Charge Switch-Pro Plasmid Miniprep&quot;</A> kit:
</P><UL><LI>pPS16_018 (FKBP - GFP 10) clone 6</LI><LI>pPS16_019 (FRB - GFP 11) clone 4</LI></UL><P>After extraction, 5 µL of each plasmids and 20 µL of DNA ladder were placed in wells and migrated at 100V during 30 min in order to assess their concentration.
</P><P>No DNA has been extracted.
</P><H4><SPAN class="mw-headline" id="Transformation_of_DH5a_cells_with_and_FKBP_-_GFP_10_.28pPS16_018.29_and_FRB_-_GFP_11_.28pPS16_019.29">Transformation of DH5a cells with and FKBP - GFP 10 (pPS16_018) and FRB - GFP 11 (pPS16_019)</SPAN></H4><P><I>By Maxence &amp; Victor</I></P><P>As we were not able to obtain good plasmid concentration after culture of glycerol stocks and plasmid extraction, transformations were done. Dh5a cells were transformed with pSB1C3 containing FKBP - GFP 10 (pPS16_018) and FRB - GFP (pPS16_019) using the usual <A href="/Team:Paris_Saclay/Experiments#heat-shocktransformation" title="Team:Paris Saclay/Experiments">protocol</A>.
</P><H3><SPAN class="mw-headline" id="BioBrick_K2039000_and_K2039001_characterization">BioBrick K2039000 and K2039001 characterization</SPAN></H3><H4><SPAN class="mw-headline" id="Culture_of_FRB_-_GFP_11_in_pSB1C3_.28pPS16_019.29_clone_4.2C_FKBP_-_GFP_10_in_pSB1C3_.28pPS16_018.29_clone_6.2C_GFP_1.9_in_pUC19_.28pPS16_009.29_clone_1_and_PhB1040_strain_594">Culture of FRB - GFP 11 in pSB1C3 (pPS16_019) clone 4, FKBP - GFP 10 in pSB1C3 (pPS16_018) clone 6, GFP 1.9 in pUC19 (pPS16_009) clone 1 and PhB1040 strain 594</SPAN></H4><P><I>By Maxence &amp; Victor</I></P><P>As we have met several issues in order to obtain plasmis pPS16_023 (gBlock ATG linker FRB + GFP 11 + gBlock ATG linker FKBP + GFP 10 + gBlock GFP 1-9), we decided to characterize our BioBricks with a Western-Blot with antibodies against GFP. For that purpose, the following clones were put on solid cultures (LB + 30 µg/mL Cm ou Amp) grown at 37°C overnight:
</P><UL><LI>pPS16_018 (FKBP - GFP 10) clone 6</LI><LI>pPS16_019 (FRB - GFP 11) clone 4</LI><LI>pPS16_009 (GFP 1.9) clone 1</LI></UL><P>Furthermore, another strain containing the full GFP was cultures in the same conditions: PhB1040 strain 594 (lac-3350 galk2 galT22 2psL179 pGFP) (Amp resistance).
</P></DIV></DIV><DIV class=" footer"><DIV class="container"><DIV class="adress"><ADRESS>Université Paris Sud
91405 Orsay, France</ADRESS></DIV><SMALL class="envers copyright">Copyright © 2016 iGEM Paris Saclay. <STRIKE>All rights reserved</STRIKE> All inspirations encouraged.*This wiki was conceived during long nights of work and a great coffee experience in the beautiful Orsay, France.</SMALL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>